NVS logo

Novartis AG (NVS) Total expenses

Annual total expenses:

$37.18B+$287.00M(+0.78%)
December 31, 2024

Summary

  • As of today (May 20, 2025), NVS annual total expenses is $37.18 billion, with the most recent change of +$287.00 million (+0.78%) on December 31, 2024.
  • During the last 3 years, NVS annual total expenses has risen by +$3.26 billion (+9.61%).
  • NVS annual total expenses is now -23.49% below its all-time high of $48.59 billion, reached on December 31, 2011.

Performance

NVS Total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVSincome statement metrics

Quarterly total expenses:

$8.96B-$1.07B(-10.68%)
March 31, 2025

Summary

  • As of today (May 20, 2025), NVS quarterly total expenses is $8.96 billion, with the most recent change of -$1.07 billion (-10.68%) on March 31, 2025.
  • Over the past year, NVS quarterly total expenses has increased by +$210.00 million (+2.40%).
  • NVS quarterly total expenses is now -35.55% below its all-time high of $13.90 billion, reached on December 31, 2011.

Performance

NVS Quarterly total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVSincome statement metrics

Total expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

NVS Total expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+0.8%+2.4%
3 y3 years+9.6%-10.1%
5 y5 years-6.1%-10.1%

NVS Total expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+9.6%-17.5%+6.3%
5 y5-year-6.5%+9.6%-17.5%+142.7%
alltimeall time-23.5%+157.5%-35.5%+173.3%

NVS Total expenses History

DateAnnualQuarterly
Mar 2025
-
$8.96B(-10.7%)
Dec 2024
$37.18B(+0.8%)
$10.03B(+5.1%)
Sep 2024
-
$9.54B(+7.8%)
Jun 2024
-
$8.86B(+1.3%)
Mar 2024
-
$8.75B(-4.9%)
Dec 2023
$36.89B(+3.9%)
$9.19B(-11.0%)
Sep 2023
-
$10.33B(+15.6%)
Jun 2023
-
$8.94B(+6.0%)
Mar 2023
-
$8.43B(-8.5%)
Dec 2022
$35.52B(+4.7%)
$9.21B(+2.8%)
Sep 2022
-
$8.96B(-17.5%)
Jun 2022
-
$10.86B(+9.0%)
Mar 2022
-
$9.96B(+170.0%)
Dec 2021
$33.92B(-14.7%)
$3.69B(-63.6%)
Sep 2021
-
$10.13B(+3.3%)
Jun 2021
-
$9.81B(-4.5%)
Mar 2021
-
$10.28B(-1.0%)
Dec 2020
$39.75B(+0.4%)
$10.39B(+2.6%)
Sep 2020
-
$10.13B(+9.2%)
Jun 2020
-
$9.27B(-7.0%)
Mar 2020
-
$9.96B(-8.5%)
Dec 2019
$39.59B(+5.0%)
$10.89B(+7.6%)
Sep 2019
-
$10.12B(+8.2%)
Jun 2019
-
$9.36B(+1.6%)
Mar 2019
-
$9.21B(-12.5%)
Dec 2018
$37.70B(+8.6%)
$10.54B(+15.2%)
Sep 2018
-
$9.15B(-0.8%)
Jun 2018
-
$9.22B(+4.9%)
Mar 2018
-
$8.79B(+104.9%)
Dec 2017
$34.70B(-15.7%)
$4.29B(-58.5%)
Sep 2017
-
$10.34B(+1.2%)
Jun 2017
-
$10.21B(+3.6%)
Mar 2017
-
$9.86B(-11.6%)
Dec 2016
$41.17B(-0.6%)
$11.15B(+10.7%)
Sep 2016
-
$10.07B(-4.9%)
Jun 2016
-
$10.59B(+13.1%)
Mar 2016
-
$9.36B(-15.9%)
Dec 2015
$41.41B(-2.7%)
$11.13B(+8.5%)
Sep 2015
-
$10.25B(-3.4%)
Jun 2015
-
$10.62B(+12.7%)
Mar 2015
-
$9.42B(-14.4%)
Dec 2014
$42.55B(+1.9%)
$11.00B(+4.2%)
Sep 2014
-
$10.56B(-1.9%)
Jun 2014
-
$10.77B(+5.4%)
Mar 2014
-
$10.22B(-9.6%)
Dec 2013
$41.73B(+3.1%)
$11.29B(+9.2%)
Sep 2013
-
$10.35B(+1.0%)
Jun 2013
-
$10.25B(-9.4%)
Mar 2013
-
$11.31B(+67.2%)
DateAnnualQuarterly
Dec 2012
$40.46B(-16.7%)
$6.76B(-39.0%)
Sep 2012
-
$11.09B(-3.0%)
Jun 2012
-
$11.43B(+2.3%)
Mar 2012
-
$11.18B(-19.6%)
Dec 2011
$48.59B(+21.4%)
$13.90B(+15.0%)
Sep 2011
-
$12.08B(+2.4%)
Jun 2011
-
$11.80B(+9.1%)
Mar 2011
-
$10.81B(-9.9%)
Dec 2010
$40.03B(+14.0%)
$12.00B(+17.2%)
Sep 2010
-
$10.23B(+14.2%)
Jun 2010
-
$8.96B(+1.3%)
Mar 2010
-
$8.85B(-15.8%)
Dec 2009
$35.12B(+4.5%)
$10.51B(+21.4%)
Sep 2009
-
$8.66B(+3.3%)
Jun 2009
-
$8.38B(+7.4%)
Mar 2009
-
$7.80B(-10.0%)
Dec 2008
$33.62B(+4.5%)
$8.67B(-0.3%)
Sep 2008
-
$8.70B(+1.9%)
Jun 2008
-
$8.53B(+10.4%)
Mar 2008
-
$7.73B(-21.7%)
Dec 2007
$32.17B(+17.1%)
$9.86B(+26.9%)
Sep 2007
-
$7.78B(+5.7%)
Jun 2007
-
$7.36B(+4.5%)
Mar 2007
-
$7.04B(-11.2%)
Dec 2006
$27.46B(+18.1%)
$7.93B(+12.5%)
Sep 2006
-
$7.04B(+9.3%)
Jun 2006
-
$6.44B(+5.8%)
Mar 2006
-
$6.09B(+24.6%)
Dec 2005
$23.25B(+9.9%)
$4.89B(-25.9%)
Sep 2005
-
$6.60B(+9.6%)
Jun 2005
-
$6.02B(+6.4%)
Mar 2005
-
$5.66B(+3.0%)
Dec 2004
$21.16B(+9.7%)
$5.50B(+2.9%)
Sep 2004
-
$5.34B(+3.1%)
Jun 2004
-
$5.18B(+0.7%)
Mar 2004
-
$5.14B(-5.5%)
Dec 2003
$19.30B(+22.2%)
$5.44B(+14.8%)
Sep 2003
-
$4.74B(+0.0%)
Jun 2003
-
$4.74B(+8.5%)
Mar 2003
-
$4.37B(+4.4%)
Dec 2002
$15.79B(+9.3%)
$4.18B(+9.6%)
Sep 2002
-
$3.82B(-8.2%)
Jun 2002
-
$4.16B(+24.4%)
Dec 2001
$14.44B(-16.6%)
-
Jun 2001
-
$3.34B(+1.9%)
Dec 2000
$17.30B(+9.7%)
-
Jun 2000
-
$3.28B
Dec 1999
$15.78B(-12.4%)
-
Dec 1998
$18.01B
-

FAQ

  • What is Novartis AG annual total expenses?
  • What is the all time high annual total expenses for Novartis AG?
  • What is Novartis AG annual total expenses year-on-year change?
  • What is Novartis AG quarterly total expenses?
  • What is the all time high quarterly total expenses for Novartis AG?
  • What is Novartis AG quarterly total expenses year-on-year change?

What is Novartis AG annual total expenses?

The current annual total expenses of NVS is $37.18B

What is the all time high annual total expenses for Novartis AG?

Novartis AG all-time high annual total expenses is $48.59B

What is Novartis AG annual total expenses year-on-year change?

Over the past year, NVS annual total expenses has changed by +$287.00M (+0.78%)

What is Novartis AG quarterly total expenses?

The current quarterly total expenses of NVS is $8.96B

What is the all time high quarterly total expenses for Novartis AG?

Novartis AG all-time high quarterly total expenses is $13.90B

What is Novartis AG quarterly total expenses year-on-year change?

Over the past year, NVS quarterly total expenses has changed by +$210.00M (+2.40%)
On this page